Astrazeneca PLC (Spons. ADRs)
[WKN: 886715 | ISIN: US0463531089]
Aktienkurse
60,750€ 0,41%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid: Ask:
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

Dato-DXd approved in US for HR+ breast cancer

20 January 2025 Datroway (datopotamab deruxtecan) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer First approval in the…

AstraZeneca Aktie: Kursziel angehoben

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von Guggenheim Securities stufen die Aktie von AstraZeneca plc (ISIN: GB0009895292, WKN: 886455, Ticker-Symbol:…